Published in

Wiley, Clinical Pharmacology & Therapeutics, 5(107), p. 1240-1255, 2019

DOI: 10.1002/cpt.1720

Links

Tools

Export citation

Search in Google Scholar

Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements

This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO